Author

Bochong Li

Observed names: B. Li, LI, Bochong

Observed institutions: Chiba University, Duke University, Peking University, National Cancer Institute, Peking University Third Hospital, Center for Cancer Research, Cullinan Oncology (United States)

ORCID: 0009-0007-9665-8948

Observed ORCIDs: 0009-0007-9665-8948, 0000-0003-1573-5379

OpenAlex ID: A5033000754

Temporal control of self‐organized pattern formation without morphogen gradients in bacteria

2013 · Stephen Payne, Bochong Li, et al. · Molecular Systems Biology · 119

Collective Space-Sensing Coordinates Pattern Scaling in Engineered Bacteria

2016 · Yangxiaolu Cao, Marc D. Ryser, et al. · Cell · 96

PDF

A novel IgG-based FLT3xCD3 bispecific antibody for the treatment of AML and B-ALL

2022 · Naveen K Mehta, Martin Pfluegler, et al. · Journal for ImmunoTherapy of Cancer · 40

Division of logic labour

2011 · Bochong Li, Lingchong You · Nature · 37

Predictive power of cell‐to‐cell variability

2013 · Bochong Li, Lingchong You · Quantitative Biology · 29

CLN-978, a novel half-life extended CD19/CD3/HSA-specific T cell-engaging antibody construct with potent activity against B-cell malignancies with low CD19 expression

2023 · Kristan Meetze, Naveen K Mehta, et al. · Journal for ImmunoTherapy of Cancer · 26

PDF

Fully connected autoencoder and convolutional neural network with attention-based method for inferring disease-related lncRNAs

2022 · Ping Xuan, Zhe Gong, et al. · Briefings in Bioinformatics · 22

Robust multi-modal prostate cancer classification via feature autoencoder and dual attention

2022 · Bochong Li, Ryo Oka, et al. · Informatics in Medicine Unlocked · 18

PDF

Elicitation of Both CD4+ and CD8+ T‐Cell‐Mediated Specific Immune Responses to HCA587 Protein by Autologous Dendritic Cells

2004 · B. Li, X. He, et al. · Scandinavian Journal of Immunology · 17

Computation of Steady-State Probability Distributions in Stochastic Models of Cellular Networks

2011 · Mark Hallen, Bochong Li, et al. · PLoS Computational Biology · 16

PDF

CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity

2024 · Naveen K. Mehta, Kavya Rakhra, et al. · Cancer Immunology Research · 14

Tension and Robustness in Multitasking Cellular Networks

2012 · Jeffrey V. Wong, Bochong Li, et al. · PLoS Computational Biology · 12

Comparative analysis of alignment algorithms for macular optical coherence tomography imaging

2023 · Craig K. Jones, Bochong Li, et al. · International Journal of Retina and Vitreous · 5

PDF

Semi-Automatic Multiparametric MR Imaging Classification Using Novel Image Input Sequences and 3D Convolutional Neural Networks

2022 · Bochong Li, Ryo Oka, et al. · Algorithms · 3

PDF

Abstract 2078: CLN-049 is a bispecific T cell engaging IgG-like antibody targeting FLT3 on AML cells

2022 · Kristan Meetze, Naveen K. Mehta, et al. · Cancer Research · 3

Stochastic Sensitivity Analysis and Kernel Inference via Distributional Data

2014 · Bochong Li, Lingchong You · Biophysical Journal · 3

PDF

Computer-aided diagnosis based on 3D deep convolutional neural network system using novel 3D magnetic resonance imaging sequences for high-grade prostate cancer

2025 · Ryo Oka, Bochong Li, et al. · Current Urology · 2

Abstract 3505: CLN-617 is an IL-2/IL-12 fusion protein with a collagen-anchoring domain that induces potent systemic anti-tumor immunity upon intra-tumoral administration

2022 · Naveen K. Mehta, Bochong Li, et al. · Cancer Research · 2

Data from CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity

2024 · Naveen K. Mehta, Kavya Rakhra, et al. · 1

Abstract 2077: Preclinical characterization of a next-generation CD19/CD3-bispecific T cell engager with extended serum half-life and superior potency against CD19-low target cells

2022 · Patrick A. Baeuerle, Naveen K. Mehta, et al. · Cancer Research · 1

Supplementary Figure S9 from CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity